DEXCOM INC (DXCM) Options Risk Score
Real-time risk analysis for DXCM options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full DXCM options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan DXCM Now — Free →
Is it risky to sell options on DEXCOM INC (DXCM) right now?
Over a 4-week expiry window, DEXCOM INC (DXCM) scores 100 out of 100 for options catalyst risk (HIGH). What pushes it there: an upcoming earnings report, 8 recent news items, 1 active legal filing, 1 recent SEC event and 40 clinical-trial catalysts, all landing inside the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on DXCM is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.
DXCM shows an IV Rank of 61, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 54%. Read IV Rank alongside the catalyst score: it says how expensive DXCM options are, while the score says whether that price is justified by a scheduled event.
DXCM is scheduled to report earnings on 2026-07-30, which falls inside a typical monthly options expiry — expect elevated implied volatility into the event and an IV crush afterward.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer